• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

series C

drawing of magnifying glass on a brain
Biotech

J&J-backed Delix secures $100M for non-hallucinatory psychedelic

Delix raised $100 million in a series C round backed by the likes of J&J to advance a phase 2-ready non-hallucinatory psychedelic for depression.
Marissa Russo Nov 9, 2026 10:30am
OMass CEO Ros Deegan

OMass’ $310M raise fuels goal to become ‘Britain’s Big Biotech’

Oct 15, 2026 2:00am
Hand passing wad of bills to other hand

Sling reels in $123M to fund oral Tepezza rival through ph. 3

Sep 16, 2026 7:00am
Pipette dripping water droplet with money symbol on it into test tube

AusperBio adds $120M series C to push hep B drug through ph. 3

Aug 28, 2026 10:26am
Alphabet letters spelling

Terremoto takes $108M series C to fuel trials of AKT1 inhibitors

Apr 15, 2026 7:43am
Inside the small intestine

Endogenex nets $50M to develop pulsed-field diabetes procedure

Mar 25, 2026 10:48am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings